Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | August 18, 2023 09:06am

Gainers

  • Alpha Tau Medical (NASDAQ:DRTS) shares increased by 16.7% to $4.2 during Friday's pre-market session. The company's market cap stands at $290.9 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) shares increased by 16.41% to $0.78. The market value of their outstanding shares is at $1.6 million.
  • Avalo Therapeutics (NASDAQ:AVTX) shares increased by 13.98% to $0.17. The market value of their outstanding shares is at $3.3 million.
  • Timber Pharmaceuticals (AMEX:TMBR) stock rose 13.53% to $1.72. The market value of their outstanding shares is at $5.2 million.
  • AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 12.21% to $0.94. The company's market cap stands at $15.4 million.
  • TRACON Pharma (NASDAQ:TCON) stock rose 12.19% to $0.23. The market value of their outstanding shares is at $6.0 million. As per the press release, Q2 earnings came out 4 days ago.

Losers

  • Athersys (NASDAQ:ATHX) shares declined by 34.7% to $0.25 during Friday's pre-market session. The company's market cap stands at $5.3 million. As per the press release, Q2 earnings came out 2 days ago.
  • CervoMed (NASDAQ:CRVO) stock decreased by 24.25% to $5.75. The company's market cap stands at $7.8 million.
  • Bone Biologics (NASDAQ:BBLG) stock fell 20.16% to $0.78. The market value of their outstanding shares is at $2.4 million.
  • Scilex Holding (NASDAQ:SCLX) stock declined by 15.72% to $3.38. The company's market cap stands at $503.8 million.
  • Predictive Oncology (NASDAQ:POAI) shares decreased by 15.47% to $4.1. The company's market cap stands at $16.5 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) stock decreased by 14.93% to $0.28. The company's market cap stands at $23.2 million. As per the press release, Q2 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACRX ATHX AVTX BBLG CRVO DRTS NBSE NRXP POAI SCLX TCON TMBR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist